The academic medical center of IU Health has an inpatient base of more than 1,300 patients. This provides residents with the opportunity for practice in diverse adult and pediatric environments, in both academic and community hospital settings.

In addition, residents will have the opportunity to participate in the development of PGY1 Residents and Doctor of Pharmacy students from both Purdue University and Butler University.

  • Competitive Salary
  • Health Benefits
  • Dental Benefits
  • Vision Benefits
  • Flexible Spending Accounts—Pretax payment of health and dependent care expenses
  • Paid Time Off—16 days
  • $1,000 travel stipend for professional meeting of resident's choice per year
  • Great Lakes Pharmacy Resident Conference expenses paid
  • Parking
    • Free parking—surface lots
    • Garage parking—available for a fee

Salary & Benefits

  • Competitive Salary
  • Health Benefits
  • Dental Benefits
  • Vision Benefits
  • Flexible Spending Accounts—Pretax payment of health and dependent care expenses
  • Paid Time Off—16 days
  • $1,000 travel stipend for professional meeting of resident's choice per year
  • Great Lakes Pharmacy Resident Conference expenses paid
  • Parking
    • Free parking—surface lots
    • Garage parking—available for a fee

The qualified applicant must possess a Doctor of Pharmacy Degree from an accredited college of pharmacy and must be eligible for Indiana licensure. Completion of a prior ASHP accredited PGY1 residency is required.

All offers are contingent upon a background check, reference check, and pre-placement health assessment, which includes a drug test. If selected for an on-site interview, a presentation and completion of clinical case will be required.

Deadline for PhORCAS Application: December 31

Application Requirements (Submitted via PhORCAS)

  • Letter of Intent
  • Curriculum Vitae
  • Three letters of recommendation
  • Official College Transcripts

How to Apply

The qualified applicant must possess a Doctor of Pharmacy Degree from an accredited college of pharmacy and must be eligible for Indiana licensure. Completion of a prior ASHP accredited PGY1 residency is required.

All offers are contingent upon a background check, reference check, and pre-placement health assessment, which includes a drug test. If selected for an on-site interview, a presentation and completion of clinical case will be required.

Deadline for PhORCAS Application: December 31

Application Requirements (Submitted via PhORCAS)

  • Letter of Intent
  • Curriculum Vitae
  • Three letters of recommendation
  • Official College Transcripts

Ambulatory Care

Overview

The PGY2 residency in ambulatory pharmacy is designed to transition PGY1 residency graduates from generalist practice that includes the ambulatory environment to specialized practice specific to the needs of ambulatory patients. PGY2 residency graduates exit with the ability to secure the agreements necessary for the establishment of a collaborative interdisciplinary ambulatory practice. They will have the capability to design and implement the services made possible by these approvals or agreements and to take full responsibility for the ongoing management of and planning for those services, including skills to assess their success via outcomes analyses. The graduates of the ambulatory care residency are empowered to treat and appropriately triage the most complex chronic and acute illnesses presented by ambulatory patients, including those with multiple disease states and serious complications. This care is delivered within the context of a long-term health care partnership with the patient that emphasizes health improvement, wellness, and disease prevention.

PGY2 ambulatory care residency graduates are primed for ambulatory practice leadership. This includes the ability to perceive the need for and deliver a wide range of programs that contribute to the public’s health, active participation in professional organizations, mentoring skills, and advanced capability to provide insightful education or training for students, pharmacy residents, pharmacy colleagues, nurses, physicians, and medical residents. The leadership skills acquired and developed by the ambulatory care residency graduates equips the individual to serve the ambulatory pharmacy practice as the expert on medication prescribing, including dealing with drug shortages, and managing the prescribing and procurement of special-order medications.

Residency Completion

  • Earn an “Achieved” status on at least 80% of the program objectives
  • Successfully complete a research project with manuscripts
  • Successfully complete an ACPE accredited presentation
  • Complete 12 months of training
  • Successfully complete at least one ambulatory care journal club presentation
  • Successfully complete a Nursing or Physician education presentation
  • Successfully precept for Butler University- Self Care Lab series
  • Participate on PGY2 Ambulatory Care Residency Advisory Council

Ambulatory Care Handout (PDF)

Ambulatory Care Rotation Structure (PDF)

Contact Information

Rachael Hiday, PharmD, MBA, BCPS, BCACP

Residency Program Director

317.962.2280

rhiday@iuhealth.org

Critical Care

Overview

The PGY2 residency in critical care pharmacy is designed to transition PGY1 residency graduates from generalist practice to specialized practice that meets the needs of critically ill patients. PGY2 residency graduates exit equipped to be fully integrated members of the interdisciplinary critical care team, able to make complex medication and nutrition support recommendations in this fast-paced environment. Training focuses on developing resident capability to deal with range of diseases and disorders that occur in the critically ill. Special emphasis is placed on the complexities of multiple organ system failure and the difficulties imposed on care when patients require life-sustaining equipment.

Graduates of the critical care residency are experienced in short-term research in the critical care environment and excel in their ability to teach other health professionals and those in training to be health professionals. They also acquire the experience necessary to exercise leadership for critical care practice in the health system.

Upon the completion of this residency the Critical Care Resident will have achieved the following objectives:

  • Have the knowledge base and pharmaceutical care skills to provide comprehensive medication management” in various critical care settings.
  • Function as an effective member of the critical care team and be integrated in the health-care system.
  • Acquire the practice skills of a qualified critical care pharmacist.
  • Provide effective educational activities in practice and didactic settings. Educate patients/families, and current and future healthcare professionals
  • Develop and complete clinical research activities. Each resident is required to complete a major project.
  • Share a commitment to the profession through participation in professional organizations.
  • Demonstrate self-assessment and self-improvement behaviors

Residency Completion

  • Earn an “Achieved” status on at least 80% of the program objectives
  • Successfully complete a research project with manuscripts
  • Successfully complete an ACPE accredited presentation
  • Complete 12 months of training
  • Successfully complete a research project with manuscript and/or poster and present at a national meeting
  • Successfully complete at least three Critical Care Journal Club presentation/participation
  • Successfully complete a Nursing Education presentation
  • Successfully complete and present a medication use evaluation

Critical Care Handout (PDF)

Critical Care Rotation Structure (PDF)

Contact Information

Quinn Czosnowski, PharmD, BCCCP

Residency Program Director

317.962.3876

qczosnow@iuhealth.org

Emergency Medicine

Overview

PGY2 pharmacy residency programs build on Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

The PGY2 residency in emergency medicine is designed to transition PGY1 residency graduates from generalist practice to specialized practice in an Emergency Department setting. Upon completion of training, graduates are equipped to be fully integrated members of the interdisciplinary Emergency Medicine team, are able to prioritize responsibilities and utilization of resources, and are able to make complex medication recommendations in this fast-paced environment. Training focuses on developing residents’ capability to deal with a wide range of diseases and disorders that occur in the emergency environment. This residency is a minimum of 12-months and a full-time practice commitment divided in to 12 block learning experiences.

Graduates of the program are empowered to treat and appropriately triage the most complex chronic and acute illnesses presented by emergency department patients, including those with multiple disease states and serious complications. They also acquire the experience necessary to exercise leadership for emergency medicine pharmacy practice in the health-care system. Graduates of the emergency medicine pharmacy residency are experienced in teaching other health-care professionals and those in training to be health-care professionals.

This residency provides rotation experience at IU Health Methodist Hospital, IU Health University Hospital, and Riley Hospital for Children at IU Health. This residency offers emergency medicine opportunities in an adult and pediatric Level One trauma center and community-based emergency departments. Additional opportunities include experience in disaster medicine, toxicology with the Indiana Poison Center and multiple other ICU and non-ICU elective rotations. A teaching certificate program, ACLS, PALS, and other training programs are also available.

The Emergency Department at Indiana University Health Methodist cares for over 100,000 patients each year. Methodist Hospital is a Level One trauma center and the only comprehensive stroke center in Indiana. Riley at IU Health is home to the only Level One Pediatric Trauma Center in Indiana. IU Health serves as teaching sites for both Butler and Purdue Universities Colleges of Pharmacy as well as Indiana University School of Medicine.

Residency Completion

  • Earn an “Achieved” status on at least 80% of the program objectives
  • Successfully complete a research project with manuscripts
  • Successfully complete an ACPE accredited presentation
  • Complete 12 months of training
  • Successfully complete a formal Critical Care/Emergency Medicine Journal Club presentation
  • Successfully complete a research project with a manuscript and present at a regional and/or national meeting
  • Successfully present at least 3 nursing, physician, or pharmacy educational presentations (1 must be ACPE accredited)
  • Successfully complete a medication use evaluation and present at the relevant clinical council meeting
  • Complete 100% of “Required Direct or Non-direct Patient Experience” topics listed within the PGY2 ED Topic Discussion Checklist

Emergency Medicine Handout (PDF)

Emergency Medicine Rotation Structure (PDF)

Contact Information

Tara Holt, PharmD, BCPS, BCCCP

Residency Program Director

317.963.3261

tholt4@iuhealth.org

Health-System Pharmacy Administration

Overview

A PGY2 health-system pharmacy administration residency builds upon PGY1 residency graduates’ competence in the delivery of patient-centered care and in pharmacy operational services to prepare residents who can assume high level managerial, supervisory, and leadership responsibilities. Areas of competence emphasized during the program include safe and effective medication-use systems, quality assurance, the management of human resources, the management of financial resources, use of technology, and advanced leadership. The residency lays the foundation for continued growth in management and leadership skills with the expectation that with fifteen years of successful pharmacy administration practice, the residency graduate should be ready to assume the directorship of a large hospital or health-system pharmacy.

Upon graduation, residents are prepared for a clinical or operational management/supervisory role in a variety of work settings including small to mid-size hospitals, large health systems, and pharmacy benefit management organizations.

Residency Completion

  • Earn an “Achieved” status on at least 80% of the program objectives
  • Successfully complete a research project with manuscripts
  • Successfully complete an ACPE accredited presentation
  • Complete 12 months of training

Health-System Pharmacy Administration Handout (PDF)

Health-System Pharmacy Administration Rotation Structure (PDF)

Contact Information

Tate N. Trujillo, PharmD, BCPS, FCCM, FASHP

Director of Pharmacy

317.962.3318

ttrujill@iuhealth.org

Hematology/Oncology

Overview

The PGY2 residency in oncology pharmacy is designed to transition PGY1 residency graduates from generalist practice to specialized practice focused on the care of patients. Residency graduates are equipped to participate as integral members of interdisciplinary teams caring for individuals with cancer, assuming responsibility for pharmaceutical care. They are able to manage the range of facilities that prepare and distribute anticancer medications – including the safe preparation, handling, and disposal of those which are hazardous. The wealth of residency graduates’ knowledge of neoplastic diseases, cancer-related and cancer treatment-related disorders, and the participation on interdisciplinary teams involved with the treatment of individuals with cancer produces a pharmacist who can successfully serve health care organizations as the ultimate resource for information about anticancer medications and for decision-making affecting the care of these patients. This includes leadership in formulary decision-making for cancer-related medications.

Exiting residents have been trained to assume responsibility for identifying and implementing opportunities to improve the medication-use system in oncology practice areas. Because of the prominent use of investigational drugs in the treatment of individuals with cancer, they also possess the skills to practice effectively in clinical environments participating in clinical research efforts.

Groomed for practice leadership, oncology pharmacy residency graduates can be expected to continue their pursuit of expertise in practice; to possess advanced skills to identify the pharmacotherapy and medication-use training needs of other health care professionals caring for individuals with cancer; to deliver effective training to those health care professionals; and to contribute to public health efforts for health improvement, wellness, and cancer screening and prevention.

Upon completing the PGY2 oncology pharmacy residency at Indiana University Health, the Resident shall competently be able to:

Demonstrate an understanding of signs and symptoms, epidemiology, risk factors, prevention and screening strategies, pathogenesis, natural history of disease, pathophysiology, clinical course, etiology, and treatment of diseases and conditions listed below.

  • Demonstrate experience managing patients with these diseases and conditions.
  • Demonstrate an understanding of the mechanism of action, pharmacokinetics, pharmacodynamics, pharmacogenomics, pharmacoeconomics, usual regimen (dose, schedule, form, route, and method of administration), indications, contraindications, interactions, adverse reactions, and therapeutics of medications and non-traditional therapies, where relevant, that are applicable to the diseases and conditions listed below.
  • Demonstrate an understanding of various forms of non-medication therapy, including lifestyle modification and the use of devices for disease prevention and treatment, for diseases and conditions listed below.

Residency Completion

  • Earn an “Achieved” status on at least 80% of the program objectives
  • Successfully complete a research project with manuscripts
  • Successfully complete an ACPE accredited presentation
  • Complete 12 months of training

Oncology Handout (PDF)

Oncology Rotation Structure (PDF)

Contact Information

Patrick J. Kiel, PharmD, BCPS, BCOP

Residency Program Director

317.948.5324

pkiel@iuhealth.org

Infectious Disease

Overview

The PGY2 residency in infectious diseases pharmacy builds on Doctor of Pharmacy (PharmD.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in the specialized area of infectious diseases. This PGY2 residency provides residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of care to patients with infectious diseases. Residents who successfully complete the accredited PGY2 residency in infectious diseases pharmacy are prepared for advanced patient care, academic, or specialized positions including antimicrobial stewardship, along with board certification in infectious diseases.

Areas of experience will include, but are not limited to:

  • Pharmacodynamics and pharmacokinetics of anti-infective
  • Diagnostic tests aimed at infectious diseases
  • Antibiotic formulary considerations and management
  • Microbiological processes and testing
  • Hospital epidemiology and infection control
  • Anti-infective resistance and practices to control measures
  • Daily antibiotic management program that includes identifying drug/microbe mismatches, antibiotic selection, IV to oral antibiotic conversion, etc.
  • Anti-infective education of medical and surgical residents and staff, pharmacy residents, students, and staff
  • Weekly infectious diseases physician/microbiologist discussions
  • Longitudinal experience in HIV disease management
  • Provision of drug information to health care professionals affiliated with Indiana University Health and surrounding health care settings
  • Preparation and publication of manuscripts and/or poster suitable for publication in the peer-reviewed literature

Residency Completion

  • Earn an “Achieved” status on at least 80% of the program objectives
  • Successfully complete a research project with manuscripts
  • Successfully complete an ACPE accredited presentation
  • Complete 12 months of training
  • Participate in the ID Clinical Council
  • Participate in Microbiology AIM meeting
  • Coordinate the Infectious Diseases Journal Club
  • Contribute to efforts of formulary management
  • Successfully complete a research project with a manuscript and/or poster and present at a national meeting

Infectious Diseases Handout (PDF)

Infectious Diseases Rotation Structure (PDF)

Contact Information

Jon Hiles, PharmD, BCPS (AQ-ID)

Residency Program Director

317.963.3044

Jhiles@iuhealth.org

Internal Medicine

Overview

The PGY2 pharmacy residency in internal medicine designed to transition PGY1 residency graduates from generalist practice to specialized practice focused on the care of adults with medical problems, primarily in the inpatient setting. Residency graduates are equipped to participate as integral members of interdisciplinary teams caring for internal medicine patients, assuming responsibility for the patient’s medication-related care. In that role, they provide the team with evidence-based medication-related information and formulate that information into expert recommendations to the team for the use of medications and other therapeutic approaches.

In addition, residency graduates’ extensive patient care experience, combined with their wealth of knowledge of medical problems and their treatment, provides for pharmacists who can successfully serve health care organizations as an essential information resource to support decisions affecting the care of internal medicine patients. Their contributions can include conducting medication-use evaluations, participating in the formulary decision process, contributing to organizational medication-use policy development including the development of guidelines and protocols, and implementation of those policies. They possess advanced skills for identifying the medication-related training needs of other health care professionals caring for internal medicine patients and for delivering effective training to them and to health care professionals in training.

Graduates of pharmacy residencies in internal medicine exhibit the characteristics of practice leaders. They are experienced in writing about and presenting on internal medicine-related pharmacy topics. They are effective advocates for the needs of internal medicine patients. They have further equipped themselves for the requirements of specialty certification and can be expected to continue their pursuit of expertise in practice through self-managed continuing professional development.

Throughout the course of residency training, the resident’s experiences shall include, but are not limited to, the following activities:

  • Provision of pharmaceutical care to hospitalized patients via participation in daily inpatient rounds on the Internal Medicine service and elective rotation services.
  • Participation in physician, pharmacist, nursing, and patient education.
  • Development and completion of a clinical research project.
  • Co-authorship of a manuscript for publication in a peer-reviewed journal.
  • Provision of mentorship and service as co-preceptor to Doctor of Pharmacy students from Butler University in the setting of Internal Medicine.
  • Involvement in classroom instruction (both didactic and case-based interactive discussion) of Doctor of Pharmacy students at Butler University.
  • Participation in a longitudinal Family Medicine outpatient Transition of Care clinic.

Residency Completion

  • Earn an “Achieved” status on at least 80% of the program objectives
  • Successfully complete a research project with manuscripts
  • Successfully complete an ACPE accredited presentation
  • Complete 12 months of training
  • Submit a manuscript for publication in a peer-reviewed journal
  • Successfully complete 2 didactic lectures at Butler University College of Pharmacy and Health Sciences
  • Successfully serve as a preceptor for the Pharmacotherapeutics Case Conference Series for 2 semesters
  • Successfully serve as the Preceptor of Record for APPE students during an IM rotation

Internal Medicine Handout (PDF)

Internal Medicine Rotation Structure (PDF)

    Contact Information

    Alexander J. Ansara , PharmD, BCPS

    Residency Program Director

    317.962.3701

    aansara@iuhealth.org

    Pediatrics

    Overview

    PGY2 pharmacy residency programs build on Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available. Indiana University Health’s Pediatric Pharmacy Residency fosters the knowledge of pediatric pharmacotherapy and promotes the provision of high quality pediatric patient care. The program develops the resident to be an independent practitioner providing high-level pharmaceutical care to acute general and subspecialty pediatric patients.

    The PGY2 pharmacy residency in pediatrics is designed to transition PGY1 residency graduates from generalist practice to specialized practice focused on the care of pediatric patients. Residency graduates are equipped to participate as integral members of interdisciplinary teams caring for pediatric patients, assuming responsibility for pharmaceutical care. These residents acquire the capacity to deliver evidence-based care to pediatric patients within the limitations presented by the shortage of research in the use of medications in this patient population.

    The PGY2 resident is expected to demonstrate an advanced understanding and practice level for the care of the pediatric patient. This will be demonstrated through the resident’s self-initiative to thoroughly investigate all aspects of pharmaceutical care. Beyond the basic care needs for the patient, examples of this are as follows (but are not limited to): appropriately challenging the rationale of drug therapy (primary team or consult recommendations), directing appropriate documentation of therapy plans and ensuring appropriate follow-through, pursing advanced literature searches to validate or refute patient therapies, demonstrate an advanced ability to appropriately prioritize patient care triaging with higher workloads, demonstrate an advanced ability to respond to all patient care needs and assignments in a timely manner with minimal back up support from preceptor. Additionally, the resident will demonstrate self-directed learning and evaluation to advance his/her understanding of all aspects of pediatric pharmaceutical care.

    Pediatric pharmacy residency graduates will serve health care organizations successfully as the ultimate resource for information about medications used in the care of children and for decision-making affecting the care of these patients. This includes leadership in decision-making related to the use or modification of guidelines for the care of individual patients and for participation in organizational planning for, implementation of, and maintenance of technology and automation systems.

    Exiting residents have been trained to assume responsibility for identifying and implementing opportunities to improve the medication-use system in pediatric practice areas. Groomed for practice leadership, pediatric pharmacy residency graduates can be expected to continue their pursuit of expertise in practice; to possess advanced skills to identify the pharmacotherapy and medication-use training needs of other health care professionals caring for pediatric patients; to deliver effective training to those health care professionals; and to contribute to public health efforts for health improvement, wellness, and disease prevention.

      Residency Completion

      • Earn an “Achieved” status on at least 80% of the program objectives
      • Successfully complete a research project with manuscripts
      • Successfully complete an ACPE accredited presentation
      • Complete 12 months of training
      • Successfully serve on a Pediatric or Academic Workgroup Committee by attending 80% of the meetings
      • Successfully participate in at least one practice management initiative affecting the pediatric population at Indiana University Health

      Pediatrics Handout (PDF)

      Pediatrics Rotation Structure (PDF)

      Contact Information

      Rebecca S. Pettit, PharmD, MBA, BCPS, BCPPS

      Residency Program Director

      317.948.9362

      rpettit1@iuhealth.org

      Pharmacy Informatics

      Overview

      The PGY2 residency in pharmacy informatics draws upon the clinical foundation of entering residents, including general competencies for managing medication-use systems and the support of optimal medication therapy outcomes. The residency trains individuals who can lead the evolution of organizations’ medication-use systems by applying pharmacy informatics principles, standards, and best practices. Graduates are adept in the language and concepts of information technology (IT), equipping them to function in the interdisciplinary environment of informatics project teams.

      PGY2 pharmacy informatics residency graduates are prepared to enter practice positions in a variety of environments. They are equipped to be the single pharmacy department source of informatics knowledge and skills, and possess the abilities needed to serve small hospitals’ technology and automation system needs. In the case of large health systems, graduates are prepared to assume roles in sub-specialties of pharmacy informatics. The broad scope of PGY2 pharmacy informatics training also enables graduates to participate in governmental health care informatics initiatives or to design innovative technology and informatics solutions within healthcare, including the software industry.

      The residency inculcates the capacity to identify where technology and automation systems can work to improve the medication-use system. Graduates are prepared to be leaders who will take the initiative to advocate the pharmacy informatics perspective and command respect for their technical skills. Graduates exit with the capacity to contribute pharmacy leadership to the project life cycle of significant pharmacy information technology or automation initiatives. Such projects include the creation of clinical decision support programming; ensuring the accuracy of medication order intent; guiding clinicians to appropriate medication use; and selection, acquisition, implementation, and evaluation of technology and automation systems that support pharmacy operations.

      Residency Completion

      • Earn an “Achieved” status on at least 80% of the program objectives
      • Successfully complete a research project with manuscripts
      • Successfully complete an ACPE accredited presentation
      • Complete 12 months of training

      Pharmacy Informatics Handout (PDF)

      Pharmacy Informatics Rotation Structure (PDF)

      Contact Information

      Lisa Starost, PharmD

      Residency Program Director

      317.963.5821

      lstarost@iuhealth.org

      Toxicology

      Overview

      The Indiana Poison Center at IU Health offers a one-year PGY2 Toxicology Pharmacy Residency. The goal of the residency is to train practitioners to perform the professional, administrative, and research roles in a regional poison center, clinical toxicology service, and academic environment.

      The residency will prepare the resident for credentialing by the American Board of Applied Toxicology through the development of clinical toxicology skills and the management of poisoned patients. The resident will provide poison center services to the state of Indiana through the Indiana Poison Center and participate in the Medical Toxicology Service, which consults on poisoned patients at IU Health Methodist Hospital, IU Health University Hospital, Riley Hospital for Children at IU Health, and Eskenazi Hospital.

      Additional opportunities include certification as an Advanced Hazmat Life Support Instructor and attendance at the North American Congress of Clinical Toxicology and ASHP Midyear Clinical Meeting.

      About the Indiana Poison Center

      The Indiana Poison Center, an accredited Regional Poison Information Center, is a non-profit, public-private partnership that provides 24-hour poison treatment advice on over 58,000 cases per year to healthcare professionals and the public. The Medical Toxicology Service consults on over 600 cases per year and has board-certified toxicologists in the areas of pharmacy, emergency medicine, neurology, and pediatrics. The Indiana Poison Center and Medical Toxicology Service serve as teaching sites for the Butler and Purdue Universities Colleges of Pharmacy as well as Indiana University School of Medicine.

      Toxicology Handout (PDF)

      Toxicology Rotation Structure (PDF)

      Contact Information

      Adam G. Overberg, PharmD, BCPS, CSPI

      Director, Indiana Poison Center

      317.962.0922

      aoverberg@iuhealth.org

      Solid Organ Transplant

      Overview

      PGY2 pharmacy residency programs build on Doctor of Pharmacy (PharmD.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in Solid Organ Transplant. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulate experience and knowledge and incorporating both into the provision of patient care of other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

      The focus of this residency is to transition a PGY1 pharmacist from a generalist to an independent clinical specialist and an essential member of an interdisciplinary team in the solid organ transplant specialty area. The PGY2 solid organ transplant residency is designed to train future transplant clinical pharmacists in both the inpatient and outpatient setting and across both abdominal and cardiothoracic solid organ types. Additionally, the residency will provide training in patients requiring mechanical circulatory support (MCS). There are optional learning experiences available in pediatric solid organ transplant. Residency graduates are equipped to participate as integral members of interdisciplinary teams caring for solid organ transplant patients, assuming responsibility for the patient’s medication-related care.

      The resident will acquire knowledge and skills in managing immunosuppression, infectious prophylaxis regimens, and post-transplant complications in solid organ transplant recipients. Additionally, the resident will gain experience in managing pharmacotherapy in patients on MCS. Graduates will exit with the ability to work collaboratively with other transplant clinical providers to design and implement both organ-specific and patient-specific care plans that optimize immunosuppression while minimizing opportunistic infections, hematologic/oncologic complications, and adverse side effects.

      Longitudinal experiences will engage the resident in necessary transplant pharmacy administration activities, educational opportunities in practice and didactic settings, and participation in quality improvement initiatives. The resident will function as an effective member of the transplant multidisciplinary team and acquire the necessary practice skills of a qualified solid organ transplant clinical pharmacist. Additionally, the resident may gain experience in professional organization participation, medication appeals, regulatory standards, and transplant administration fundamentals.

        Residency Completion

        • Earn an “Achieved” status on at least 80% of the program objectives
        • Successfully complete a research project with manuscripts
        • Successfully complete an ACPE accredited presentation
        • Complete 12 months of training
        • Complete a quality assurance and performance improvement (QAPI) project
        • Complete 2 educational activities to transplant clinicians
        • Complete 2 journal clubs focusing on transplant-related topics

        Solid Organ Transplant Handout (PDF)

        Solid Organ Transplant Rotation Structure (PDF)

        Contact Information

        Erin Lushin, PharmD, BCPS

        Residency Program Director

        317.963.2948

        elushin@iuhealth.org